Zimmer Biomet (ZBH) posted earnings per share in line with the Zacks Consensus Estimate. However its revenue missed the Zacks Consensus Estimated by a small magnitude.
On Sep 2, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
Zimmer Biomet's (ZBH) adjusted earnings per share of $2.02 beat this estimate by 3.1%.
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
Zimmer Biomet (BMO) posted revenues of $1.904 billion, comfortably beating the Zacks Consensus Estimate for revenues of $1.880 billion.
Lots Happening in MedTech: Should You Buy These Stocks?
Zimmer Biomet???s (ZBH) adjusted earnings per share of $2.09 beat the Zacks Consensus estimate by a nickel.
On Jan 15, 2015, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
Dec 19 (Reuters) - A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.
Zimmer Holdings (ZMH) reported third-quarter 2014 adjusted earnings per share of $1.35.
Zimmer Holdings Inc. (ZMH) is scheduled to report its third-quarter 2014 results before the opening bell on Oct 23.
Zimmer Holdings (ZMH) recently disclosed that it has acquired Massachusetts-based ETEX Holdings.
Zimmer Holdings (NYSE:ZMH) will hear back from EU antitrust authorities by Oct. 3 over whether or how it will be allowed to pursue its $13.4B takeover of rival Biomet (Pending:BMET).Zimmer originally sought approval in June, but the EU regulator paused the review because the company's submission was lacking details. Post your comment!
On Aug 8, 2014, we issued an updated research report on Zimmer Holdings, Inc. (ZMH).
Zimmer Holdings (ZMH -3.5%) Q2 results: Net Sales: $1,182.9M (+1.1%), Reconstructive: $890.4M (+2.6%), Dental: $61.1M (-0.5%), Trauma: $78.8M (+6.3%), Spine: $52.2M (-3.7%), Surgical & Other: $100.4M (-10.2%); COGS: $333.2 (+3.0%); Gross Profit: $849.7M (+0.4%); R&D Expense: $48.1M (-12.4%); SG&A Expense: $455.8M (0.5%); Operating Income: $259.3M (+23.2%); Net Income: $176.1M (+16.1%); EPS: $1.03 (+15.7%); Quick Assets: $1,698.0M (-6.1%); CF Ops (1H): $442.9M (+19.6%).2014 Guidance: revenue growth: 2.0 - 3.0% from 3.0 - 5.0%; diluted GAAP EPS: $4.65 - 4.75 from $4.90 - 5.10; diluted non-GAAP EPS: $6.00 - 6.10 from $6.00 - 6.20. Post your comment!
Zimmer Holdings (ZMH) reported second-quarter 2014 adjusted earnings per share of $1.49, up 4.2% year over year.